taking tirzepatide and semaglutide together vs. Tirzepatide: Which GLP-1 Wins? Semaglutide and tirzepatide are both

8.5 Sitagliptin IP Valuation: Patent Landscape Analysis Sitagliptins primary composition-of-matter patent in the United States expired in 2022, and Merck had previously agreed to a settlement with several generic manufacturers granting patent licenses for generic sitagliptin entry at that date

When combined, these effects require baseline and periodic monitoring including lipid panels, glucose tolerance, blood pressure, and hematocrit levels

Yazidi M, Kamoun E, Hadj Taieb S, Rejeb O, Mahjoub S, Maryam S, et al

Manuscript under review

Although relatively few studies have examined the combination directly, there is a substantial body of research investigating each peptide individually